Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 10 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 4.4 +/-0.4%)
Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 10 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 2.4 +/-0.5%)
Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 10 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 93.2 +/-0.9%)
Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 5 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 4.4 +/-0.4%)
Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 5 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 2.4 +/-0.5%)
Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 5 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 93.2 +/-0.9%)
Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 1 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 4.4 +/-0.4%)
Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 1 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 2.4 +/-0.5%)
Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 1 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 93.2 +/-0.9%)
Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at G2/M phase at 10 uM after 30 hrs by flow cytometer (Rvb = 17.1 +/-2.1%)
Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at S phase at 10 uM after 30 hrs by flow cytometer (Rvb = 33.1 +/-0.3%)
Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at G0/G1 phase at 10 uM after 30 hrs by flow cytometer (Rvb = 49.8 +/-1.5%)
Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at G2/M phase at 1 uM after 30 hrs by flow cytometer (Rvb = 17.1 +/-2.1%)
Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at S phase at 1 uM after 30 hrs by flow cytometer (Rvb = 33.1 +/-0.3%)
Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at G0/G1 phase at 1 uM after 30 hrs by flow cytometer (Rvb = 49.8 +/-1.5%)